X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8319) 8319
Newsletter (1310) 1310
Publication (354) 354
Newspaper Article (125) 125
Magazine Article (84) 84
Book Review (80) 80
Dissertation (49) 49
Book Chapter (34) 34
Conference Proceeding (24) 24
Trade Publication Article (11) 11
Transcript (9) 9
Government Document (3) 3
Book / eBook (2) 2
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
naproxen (6315) 6315
humans (3566) 3566
male (2133) 2133
female (2070) 2070
index medicus (1716) 1716
adult (1415) 1415
pharmacology & pharmacy (1407) 1407
naproxen - therapeutic use (1395) 1395
middle aged (1287) 1287
ibuprofen (1132) 1132
animals (1031) 1031
drugs (969) 969
naproxen - adverse effects (964) 964
aged (954) 954
research (907) 907
nonsteroidal antiinflammatory drugs (846) 846
anti-inflammatory agents, non-steroidal - therapeutic use (823) 823
anti-inflammatory agents, non-steroidal - adverse effects (795) 795
analysis (788) 788
double-blind method (767) 767
naproxen - pharmacology (752) 752
naproxen - administration & dosage (686) 686
nonsteroidal anti-inflammatory drugs (651) 651
naproxen - chemistry (610) 610
osteoarthritis (560) 560
rats (550) 550
reports (502) 502
chemistry, analytical (493) 493
adolescent (469) 469
aspirin (467) 467
celecoxib (467) 467
diclofenac (465) 465
anti-inflammatory agents, non-steroidal - administration & dosage (445) 445
pain (442) 442
solubility (431) 431
rheumatoid-arthritis (417) 417
chemistry, multidisciplinary (414) 414
medicine, general & internal (405) 405
anti-inflammatory agents, non-steroidal - pharmacology (403) 403
clinical trials as topic (401) 401
pharmaceuticals (395) 395
arthritis, rheumatoid - drug therapy (389) 389
treatment outcome (381) 381
pharmaceutical industry (371) 371
risk factors (370) 370
indomethacin (359) 359
care and treatment (358) 358
drug therapy (355) 355
kinetics (354) 354
dose-response relationship, drug (347) 347
rheumatology (341) 341
time factors (340) 340
naproxen sodium (330) 330
osteoarthritis - drug therapy (328) 328
rofecoxib (323) 323
chemistry, physical (312) 312
arthritis (311) 311
universities and colleges (308) 308
double-blind (307) 307
anti-inflammatory agents, non-steroidal - chemistry (303) 303
analgesics (302) 302
environmental sciences (297) 297
chemistry, medicinal (294) 294
inflammation (280) 280
nsaids (279) 279
cox-2 inhibitors (278) 278
risk (278) 278
biochemistry & molecular biology (273) 273
migraine (273) 273
ketoprofen (265) 265
naproxen - pharmacokinetics (264) 264
chemistry (263) 263
enantiomers (260) 260
clinical trials (253) 253
drug therapy, combination (248) 248
medical research (248) 248
efficacy (238) 238
administration, oral (234) 234
naproxen - metabolism (234) 234
biochemical research methods (231) 231
pharmacokinetics (229) 229
cyclooxygenase inhibitors - adverse effects (228) 228
aged, 80 and over (218) 218
medicine, experimental (215) 215
adsorption (214) 214
drug interactions (214) 214
cyclooxygenase inhibitors - therapeutic use (213) 213
mice (212) 212
acetaminophen (211) 211
clinical neurology (211) 211
drug delivery systems (211) 211
stereoisomerism (210) 210
gastrointestinal toxicity (204) 204
dosage and administration (203) 203
hydrogen-ion concentration (203) 203
naproxen - blood (203) 203
anti-inflammatory drugs (201) 201
nanoparticles (197) 197
pain - drug therapy (195) 195
pain measurement (193) 193
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9358) 9358
German (125) 125
Spanish (76) 76
Chinese (74) 74
Italian (48) 48
French (45) 45
Russian (37) 37
Japanese (34) 34
Norwegian (30) 30
Polish (23) 23
Dutch (16) 16
Danish (15) 15
Turkish (14) 14
Korean (13) 13
Portuguese (9) 9
Hungarian (6) 6
Swedish (6) 6
Croatian (5) 5
Czech (5) 5
Slovak (4) 4
Hebrew (3) 3
Persian (3) 3
Arabic (2) 2
Bosnian (2) 2
Ukrainian (2) 2
Finnish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Applied Catalysis B, Environmental, ISSN 0926-3373, 02/2018, Volume 221, p. 510
Display Omitted 
Naproxen
Journal Article
The Journal of Supercritical Fluids, ISSN 0896-8446, 03/2013, Volume 75, p. 21
Display Omitted 
Naproxen
Journal Article
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, ISSN 1386-1425, 06/2012, Volume 92, p. 122
Effect of micelles of C.sub.n TAB and Igepals on the modulated photophysical properties of drug molecule NP, binding constant (K.sub.b) and Stern-Volmer... 
Naproxen
Journal Article
JAMA, ISSN 0098-7484, 11/1999, Volume 282, Issue 20, pp. 1921 - 1928
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 03/2010, Volume 159, Issue 6, pp. 1236 - 1246
Background and purpose:  Hydrogen sulphide is an important mediator of gastric mucosal defence. The use of non-steroidal anti-inflammatory drugs continues to... 
gastrointestinal | naproxen | blood pressure | arthritis | inflammation | cyclooxygenase | ulcer | hydrogen sulphide | non-steroidal anti-inflammatory drug | mucosal defence | non‐steroidal anti‐inflammatory drug | Hydrogen sulphide | Cyclooxygenase | Mucosal defence | Naproxen | Non-steroidal anti-inflammatory drug | Ulcer | Arthritis | Blood pressure | Inflammation | Gastrointestinal | RHEUMATOID-ARTHRITIS | MUCOSAL LESIONS | OXIDE DONATOR NAPROXCINOD | GASTROINTESTINAL-TRACT | BLOOD-PRESSURE | SELECTIVE CYCLO-OXYGENASE-2 INHIBITORS | GASTRIC DAMAGE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | Hydrogen Sulfide - metabolism | Naproxen - analogs & derivatives | Arthritis, Experimental - drug therapy | Intestinal Mucosa - metabolism | Rats, Wistar | Dinoprostone - biosynthesis | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Male | Gastric Mucosa - metabolism | Intestinal Mucosa - drug effects | Stomach Ulcer - enzymology | Arthritis, Experimental - metabolism | Intestine, Small - enzymology | Naproxen - pharmacokinetics | Intestinal Mucosa - enzymology | Gastric Mucosa - drug effects | Blood Pressure - drug effects | Molecular Structure | Hypertension - enzymology | Naproxen - analysis | Naproxen - adverse effects | Stomach Ulcer - metabolism | Gastric Mucosa - enzymology | Stomach Ulcer - drug therapy | Rats | Naproxen - therapeutic use | Hypertension - metabolism | Naproxen - chemistry | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Intestine, Small - drug effects | Cyclooxygenase 2 - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Mice | Arthritis, Experimental - enzymology | Cyclooxygenase 1 - metabolism | Intestine, Small - metabolism | Toxicity | Rodents | Ulcers | Research Papers
Journal Article
Analytica Chimica Acta, ISSN 0003-2670, 09/2006, Volume 577, Issue 1, p. 107
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 12/2014, Volume 24, Issue 24, pp. 5587 - 5592
A novel set of compounds containing a unique ‘1-(nitrooxy)ethyl ester’ group act as true prodrugs of aspirin and exhibit excellent oral bioavailability,... 
Nitric oxide donors | NO-NSAIDs | NO-aspirin | Gastric-sparing NSAIDs | NO-naproxen | Gastric-sparing | NSAIDs | CHEMISTRY, MEDICINAL | MECHANISM | HYDROLYSIS | CHEMISTRY, ORGANIC | BIOLOGICAL-MEMBRANES | 2-ACETOXYBENZOATE | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | KINETICS | NSAIDS | ESTERS | IMPROVED DELIVERY | Naproxen - analogs & derivatives | Thromboxane B2 - metabolism | Area Under Curve | Humans | Naproxen - pharmacology | Aspirin - pharmacokinetics | Half-Life | Nitrates - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Blood Platelets - enzymology | Prodrugs - chemistry | Platelet Aggregation Inhibitors - toxicity | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Nitrates - chemistry | Naproxen - pharmacokinetics | Drug Design | Gastric Mucosa - drug effects | Cyclooxygenase 1 - chemistry | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation Inhibitors - pharmacokinetics | Aspirin - pharmacology | Blood Platelets - drug effects | Nitrates - pharmacokinetics | Nitrates - toxicity | Cyclooxygenase 2 - chemistry | Drug Stability | Rats | Rats, Sprague-Dawley | Anti-Inflammatory Agents, Non-Steroidal - toxicity | Naproxen - chemistry | Animals | Prodrugs - pharmacokinetics | Aspirin - analogs & derivatives | Cyclooxygenase 2 - metabolism | Platelet Aggregation Inhibitors - chemistry | Prodrugs - toxicity | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Aspirin - chemistry | Naproxen - toxicity | ROC Curve | Aspirin - toxicity | Cyclooxygenase 1 - metabolism | Nitric Oxide - metabolism | Prodrugs - pharmacology | Aspirin | Naproxen | Nitric oxide
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | RHEUMATOID-ARTHRITIS | CYCLO-OXYGENASE-2 | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY | DICLOFENAC | PREVENTION | RISK | OSTEOARTHRITIS | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Bleeding | Incidence | Prostaglandin endoperoxide synthase | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Antiinflammatory agents | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment
Journal Article
Bioresource Technology, ISSN 0960-8524, 2010, Volume 101, Issue 7, pp. 2159 - 2166
Journal Article
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2519 - 2529
BACKGROUND The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), remains uncertain. METHODS... 
MEDICINE, GENERAL & INTERNAL | PAIN | METAANALYSIS | OSTEOARTHRITIS | CLINICAL-TRIAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | Celecoxib - adverse effects | Naproxen - adverse effects | Ibuprofen - therapeutic use | Humans | Middle Aged | Male | Risk | Celecoxib - therapeutic use | Naproxen - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Intention to Treat Analysis | Kidney Diseases - chemically induced | Cardiovascular Diseases - mortality | Female | Aged | Cardiovascular Diseases - chemically induced | Ibuprofen - adverse effects | Gastrointestinal Diseases - chemically induced | Care and treatment | Safety and security measures | Naproxen | Ibuprofen | Dosage and administration | Arthritis | Celecoxib | Diagnosis | Cardiovascular diseases | Risk factors | Cardiovascular disease | Side effects | Nonsteroidal anti-inflammatory drugs | Pain management | Myocardial infarction | Fees & charges | Hemorrhage | Pain | Motivation | Analgesics | Safety | Drug dosages | Cerebral infarction | Statistical analysis | Anemia | Committees | FDA approval | Patients | Manuscripts | Rheumatoid arthritis | Collaboration | Osteoarthritis | Pharmaceuticals
Journal Article